Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mexican genomics institute plans incubator:

This article was originally published in Clinica

Executive Summary

Mexico's genomic institute, (Inmegen), is considering establishing a commercial incubator. This week, the institute received funding to launch a feasibility study for the project, which seeks to speed up the development of new technologies for use in the national health service, linked to the national bio- and medical technology industries. Inmegen is the result of an alliance involving the health ministry, the national science and technology council, the national autonomous university of Mexico (UNAM) and the Mexican healthcare foundation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel